Unknown

Dataset Information

0

Individualized Tamoxifen Dose Escalation: Confirmation of Feasibility, Question of Utility.


ABSTRACT: Tamoxifen may require metabolic activation to endoxifen for efficacy in treating hormone receptor-positive breast cancer. Dose escalation in patients with low endoxifen concentrations could enhance treatment efficacy. This approach is clinically feasible, and successfully increases endoxifen concentrations; however, it is unknown whether patients benefit from individualized tamoxifen dose escalation. Clin Cancer Res; 22(13); 3121-3. ©2016 AACRSee related article by Fox et al., p. 3164.

SUBMITTER: Hertz DL 

PROVIDER: S-EPMC4930675 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6598548 | biostudies-literature
| S-EPMC6461928 | biostudies-literature
| S-EPMC4943390 | biostudies-literature
| S-EPMC4589558 | biostudies-literature
| S-EPMC4312491 | biostudies-literature
| S-EPMC6543868 | biostudies-literature
| 12385 | ecrin-mdr-crc
| S-EPMC6368183 | biostudies-literature
| S-EPMC9841260 | biostudies-literature
| S-EPMC7029228 | biostudies-literature